Jaime Gómez-Zamudio

Author

Jaime Gómez-Zamudio

Also Known As

Fernando Suarez-Sánchez, J Gómez-Zamudio, J. Gomez-Zamudio, J. Gómez‐Zamudio, J. H. Gómez‐Zamudio, Jaime Gomez-Zamudio, Jaime Gomez‐Zamudio, Jaime Goméz-Zamudio, Jaime Gómez-Zamudio, Jaime H Gómez-Zamudio

Publications

547

Citations

H-Index

Concepts

All Affiliations

Hospital de Especialidades Centro Medico Nacional Siglo XXI Mexican Social Security Institute McMaster University Instituto Nacional de Salud Pública

About

Jaime Gómez-Zamudio is an author at Hospital de Especialidades specializing in medicine, obesity, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	236
2	Public Health	3	3	62
3	Biochemistry	2	2	50
4	Health Sciences	1	1	20
5	Cell Biology	1	1	26

Jaime Gómez-Zamudio

Publications

422

Citations

H-Index

Page 1

	Year	Citations
Antidiabetic, antihyperlipidemic and anti-inflammatory effects of tilianin in streptozotocin-nicotinamide diabetic rats Jorge Alberto García-Díaz, Gabriel Navarrete‐Vázquez, Sara García‐Jiménez, Biomedicine & Pharmacotherapy InflammationAnti-inflammatoryMedicinePhysiologyDiabetes	2016	52
High Thyroid-stimulating Hormone Levels Increase Proinflammatory and Cardiovascular Markers in Patients with Extreme Obesity Jaime Gómez-Zamudio, Victoria Mendoza‐Zubieta, Aldo Ferreira‐Hermosillo, Archives of Medical Research ObesityMetabolic SyndromeCardiovascular MarkersMetabolic DisorderThyroid Disease	2016	43
Assessing the effects of 35 European‐derived BMI‐associated SNPs in Mexican children Arkan Abadi, Jesús Peralta‐Romero, Fernando Suárez‐Obando, Obesity	2016	38
Altered Glycemic Control Associated With Polymorphisms in the <i>SLC22A1</i> (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study Carlos Alberto Reséndiz‐Abarca, Eugenia Flores‐Alfaro, Fernando Suárez‐Sánchez, The Journal of Clinical Pharmacology	2019	34
<i>APOA5</i> and <i>APOA1</i> polymorphisms are associated with triglyceride levels in Mexican children Fernando Suárez‐Sánchez, Miguel Klünder‐Klünder, Adán Valladares‐Salgado, Pediatric Obesity	2016	31
Antidiabetic, antidyslipidemic and toxicity profile of ENV-2: A potent pyrazole derivative against diabetes and related diseases Eduardo Hernández‐Vázquez, Hugo Ocampo-Montalban, Litzia Cerón‐Romero, European Journal of Pharmacology Pharmaceutical SciencePotent Pyrazole DerivativeBiochemistryMedicineDiabetes	2017	29
Association between PPAR-γ2 Pro12Ala genotype and insulin resistance is modified by circulating lipids in Mexican children Carolina Stryjecki, Jesús Peralta‐Romero, Akram Alyass, Scientific Reports NutritionMetabolic DisorderCardiometabolic RiskGenetic EpidemiologyInsulin Signaling	2016	27
Participation of the IKK-α/β complex in the inhibition of the TNF-α/NF-κB pathway by glycine: Possible involvement of a membrane receptor specific to adipocytes Erika Contreras-Nuñez, Gerardo Blancas‐Flores, Miguel Cruz, Biomedicine & Pharmacotherapy InflammationMolecular PharmacologyMolecular PhysiologySignal TransductionSignaling Pathway	2018	26
Vascular endothelial function is improved by oral glycine treatment in aged rats Jaime Gómez-Zamudio, Rebeca García-Macedo, M. L. Lázaro‐Suárez, Canadian Journal of Physiology and Pharmacology AgingLipid PeroxidationRenal InflammationVascular Endothelial FunctionOxidative Stress	2015	21
Expression of obesity- and type-2 diabetes-associated genes in omental adipose tissue of individuals with obesity Mario Molina-Ayala, Virginia Rodríguez-Amador, Rocío Suárez‐Sánchez, Gene ObesityMetabolic SyndromeInsulin SignalingMetabolic DisorderType-2 Diabetes-associated Genes	2022	20

Page 1